Back to search results

Promoting Resilience in Women With Breast Cancer (PRISM -MBC)

This study is testing a program called Promoting Resilience in Women with Breast Cancer (PRISM) for people with metastatic breast cancer. PRISM is a short program that teaches skills like managing stress, setting goals, changing negative thoughts, and finding meaning. It's delivered one-on-one by trained coaches and can include an optional family session. The main goal is to see if this program helps improve resilience (your ability to bounce back from difficulties) and other patient-reported outcomes over 3 months. The study is especially interested in how PRISM works for Black women with metastatic breast cancer, as they often face unique challenges. You might be able to join if you are an adult (18 years or older) with metastatic breast cancer and are willing to follow the study procedures.

Study design
This is an interventional study, meaning participants will receive the PRISM program. It aims to enroll 120 participants.
What's involved
You would participate in the PRISM program and have your resilience score measured at the start and after 3 months.
Compensation
Not stated in the trial record.
Follow-up
Your resilience score will be measured at 3 months after starting the program.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06855654

Promoting Resilience in Women With Breast Cancer (PRISM -MBC)

Recruiting
NAAges 18+InterventionalSupportive care
UNC Lineberger Comprehensive Cancer Center
~120 participants
Updated 2026-05-15 on ClinicalTrials.gov
What's tested:Promoting Resilience in Women with Breast Cancer (PRISM)

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Resilience Score Change
Measured over Baseline and 3 months

Conditions

Breast Cancer
Metastatic Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

2 sites across 2 states
Alabama1
North Carolina1

Study leadership

  • Katie Reeder-Hayes, MD, MBA, MSCR · PRINCIPAL_INVESTIGATOR · UNC Lineberger Comprehensive Cancer Center

Who to contact

Erin Laurie-Zehr
[email protected]
(919)-445-4941
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.
Participants are willing and able to comply with study procedures based on the judgement of the investigator.
Male and female patients of age \>18 years.
Pathologic diagnosis of metastatic breast cancer within 182 days prior to enrollment date.
Able to answer surveys and participate in counseling sessions in English (the patient's first language is not required to be English).
Indicate intent to receive ongoing cancer care at the enrolling institution.

Exclusion

Patient unwilling or unable to complete surveys via one of the following methods: (a) paper survey completed in clinic or mailed directly to patient's home address, including a pre-addressed, pre-stamped return envelope in the mailed survey packet, or (b) electronic survey links sent via emails or text link on a mobile device, tablet, laptop, or desktop computer.
Patient unwilling or unable to provide verbal or signed consent to participate.
Participant cannot read English.
Patient has permanently discontinued cancer-directed therapy or does not intend to receive any cancer-directed therapy, is receiving home or residential hospice care, is hospitalized, or is described as likely to die within 90 days or actively dying in last provider documentation, at the time of enrollment.

What this trial measures

  • Resilience Score ChangeBaseline and 3 months

    Resilience Score Change will be assessed baseline to 3 months using Connor Davidson Resilience Score, overall and stratified by race (Black/non-Black).